valdecoxib
Noun: A nonsteroidal anti-inflammatory drug (NSAID) that specifically inhibits the cyclooxygenase-2 (COX-2) enzyme. It was marketed under the brand name Bextra and was used to relieve pain and inflammation, particularly for conditions like osteoarthritis and menstrual pain, with the intended benefit of reducing gastrointestinal side effects compared to traditional NSAIDs.
Valdecoxib is used as a proper noun referring to a specific pharmaceutical compound. It is typically used in medical, pharmacological, and regulatory contexts. - The drug valdecoxib was withdrawn from the market due to safety concerns. - Studies compared the efficacy of valdecoxib to other pain relievers.
- Therapeutic Use: Valdecoxib belonged to a class of drugs known as COX-2 selective inhibitors, designed to provide anti-inflammatory and analgesic effects while minimizing damage to the stomach lining.
- Regulatory Status: Discussion of often involves its historical approval and subsequent voluntary withdrawal from the U.S. and other markets in 2005 following evidence of increased cardiovascular risk and rare, serious skin reactions.
- Bextra: The primary brand name under which valdecoxib was sold.
- COX-2 inhibitor: The class of drugs to which valdecoxib belongs. Other examples include celecoxib and rofecoxib.
- NSAID (Nonsteroidal Anti-Inflammatory Drug): The broader drug category.
- COX-2 inhibitor (class synonym)
- Bextra (brand name synonym)
Valdecoxib is not commonly used in idioms, phrasal verbs, or casual language. Its usage is almost exclusively technical and historical within the fields of medicine and pharmacology.
-
a Cox-2 inhibitor (trade name Bextra) that relieves pain and inflammation without harming the digestive tract
Khám phá thêm
Các từ liên quan
Từ đồng nghĩa
